EZH2 is affected by somatic gain‐of‐function mutations in 30% of GCB‐DLBCL and FL patients.115, 116 These mutations are always heterozygous and most commonly affect the Y641 residue within the catalytic pocket of the EZH2 enzymatic SET domain. This evidence concerns the gene EZH2 and diffuse large B-cell lymphoma.